Its variant III mutation (EGFRvIII), characterized by an in-frame deletion in exons 2–7, is common (25%–50%) in GBM and produces a truncated EGFR protein without the extracellular ligand-binding domain, leading to its ligand-independent constitutive activation [5]. The gene discussed is EGFR; the disease is glioblastoma.